Analysis on the World's Bioinformatics Market 2017-2019 and Forecast to 2023 - Review of Challenges & Opportunities following the Adoption of High-Throughput Technologies

News provided by

Nov 21, 2019, 15:15 ET

DUBLIN, Nov. 21, 2019 /PRNewswire/ -- The "Bioinformatics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

The scope of the study encompasses the global bioinformatics market based on geography, category, and application. It provides a detailed analysis of recent advances in omic technologies and examines their impact on the bioinformatics market.

It discusses the ways in which bioinformatics has been utilized by the pharma and biotech industries to streamline the research and development (R&D) process and improve efficiencies. It provides a detailed analysis of the leading countries, companies, and technologies that will drive the field forward.

The report includes:

Comprehensive details of the global bioinformatics market and relevant technologies
Analyses of global market trends with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
Assessment of the market trends and analysis regarding industry service providers and software solution developers, as well as information technology (IT) and bioinformatics service providers that support the pharma and biotech industries
Review of challenges and opportunities underlying in the bioinformatics market following the adoption of high-throughput technologies such as next-generation sequencing (NGS), the analysis of big data, and the emergence of cloud-based solutions
Insight into the sequencing and pharmaceutical R&D applications of bioinformatics in drug development and clinical trials, including cheminformatics, next-generation sequencing, metagenomics and data management systems
A look at the investigational new drug applications, NDA approvals, leading EHRs providers, mobile health technologies, and recent partnerships and agreements in the pharmaceutical and bioinformatic sectors
Profile description of key pharmaceutical and biotechnology companies, including Dassault Systemes Biovia, Genedata AG, PerkinElmer Informatics Inc., Qlucore AB, and Syngene International

The rapid growth in raw data generation and advances in IT software and infrastructure have enabled researchers to integrate disparate datasets in order to decipher complex biological processes and develop predictive models of disease, for the purposes of identifying and validating novel biomarkers and developing precision medicines.

Since scientists unraveled the blueprint of the human genome more than 10 years ago, they have been exploring new ways to utilize omic data to understand more complex diseases. Researchers are eager to analyze as many different types of data as possible to gain a better understanding of what is happening at the cellular and molecular levels. Service providers have developed new analytical tools and IT infrastructures to enable scientists to interrogate complex data sources and quickly and efficiently disseminate information for better decision-making to achieve this goal.

More recently, improvements in cloud computing capabilities, advances in data analysis software services and the growth of NGS technologies have helped to expand the evaluation of available datasets, allowing researchers to build systems biology models of various diseases.

Key Topics Covered

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Intended Audience
Information Sources
Methodology
Geographic Breakdown

Chapter 2 Summary and Highlights

Chapter 3 Global Bioinformatics Market: Overview

Goal of Bioinformatics
Biological Data Sources
Bioinformatics in Systems Biology
Precision Medicine
Bioinformatics in Drug Development
Cheminformatics
Next-Generation Sequencing
Metagenomics
Database Management Systems
Market Trends
Precision Medicine and Biomarker Identification
Cloud-Based Solutions
Shift Toward Value-Based Care
Market Challenges
Data Integration
Data Reliability and Standardization
End-to-End Workflows
Current Market
Market by Region
Market by Category
Public Funding
Private Funding
Market by Application

Chapter 4 Bioinformatics: Data Generation and Data Management

Information Overload
Data Volume
Data Variety
Data Velocity
Data Veracity
Software Scalability and Validity
Technologies Behind Big Data Generation
Genomics
Exponential Growth in NGS Software Tools
Functional Genomics
CRISPR Cas9 System
Proteomic Advances
Qualitative Proteomics
Quantitative Proteomics
Structural Proteomics
Advances in MS-Based Proteomics Technology for Exploring Triple-Negative Breast Cancer
Sample Preparation Assays
Tagging/Affinity Methods
Utility of Proteomics to Identify Biomarkers
Investments in Structural Genomics and Open Science
Interaction Proteomics
Applications in Drug Discovery
Bottom-Up vs. Top-Down Proteomics
Emergence of Glycomics
Human Proteome Organization and Human Proteome Project Initiatives
Transcriptomic Advances
RNA Sequencing
Co-Expression and Single-Cell RNA-Seq
Metabolomic Advances
Advances in Cheminformatics
Emerging Technologies
Metagenomic Advances
Epigenomic Advances
Pharmacogenomic Advances
Pharmacogenomics and Precision Medicine
Value-Based Decisions
Pharmacogenomics and R&D
International Serious Adverse Events Consortium
Pharmacogenomic Software
Toxicogenomic Advances
Customized Toxicogenomic Platforms
Database Management Services
Market Dynamics

Chapter 5 Bioinformatics: Data Analysis and Software

Introduction
Data Analysis Software
Biosimulation Models
Market Analysis

Chapter 6 Bioinformatics: Data Processing and Storage

Mind the Gap
Information Technology Infrastructure
High-Performance Computing
High-Performance Computer Clusters
Cloud Computing
Data as a Service
Infrastructure as a Service
Platform as a Service
Software as a Service
Security as a Service
Cloud Computing Challenges
Future of Cloud Computing
Market Analysis

Chapter 7 Bioinformatics: Sequencing Services and Platforms

Market Analysis
Comparative Analysis Across Market Segments, 2017 and 2023
Sequencing Services
Sequencing Platforms
Sequence Analysis Platforms
Sequence Alignment Platforms
Sequence Manipulation Platforms

Chapter 8 Bioinformatics: Sequencing Applications

Market Analysis
Agrigenomics
Clinical and Medical
Genealogy
Other Fields

Chapter 9 Bioinformatics Applications in Pharmaceutical R&D

Introduction
Drug Discovery and Development Process
Target Identification
Target Validation
Lead Identification
Lead Optimization
Clinical Research: Drug Development
Preclinical Experiments
Investigational New Drug Applications
Clinical Trials
New Drug Application
NDA Approval
Post-Launch Ongoing Studies and Phase IV Clinical Trials
Electronic Health Records
Mobile Health Technologies
Recent Pharmaceutical and Bioinformatics Alliances and Partnerships
Conclusions

Chapter 10 Market Trends and Analysis

North America
United States
Canada
Europe
United Kingdom
Germany
Switzerland
Asia-Pacific
India
China
Conclusions

Chapter 11 Company Profiles

3rd Millennium Inc.
Biomatters Ltd. Geneious
Compugen Ltd.
Dassault Systemes Biovia
Dnastar, Inc.
Genedata Ag
Geneva Bioformatics (Genebio) Sa
Genologics Lifesciences Software Inc.
Genomatix Software Gmbh
GNS Healthcare Inc.
GVK Biosciences Pvt. Ltd.
Inte Ligand Software Entwicklungs Und Consulting Gmbh
Illumina Inc.
Macvector Inc.
Molecular Connections Pvt. Ltd.
Molecular Networks Gmbh
Nonlinear Dynamics Ltd.
Ocimum Biosolutions Ltd.
Perkinelmer Informatics Inc.
Personalis Inc.
Qlucore Ab
Real Time Genomics Inc.
Smartgene Services Sarl
Strand Life Sciences
Syngene International

For more information about this report visit https://www.researchandmarkets.com/r/ywqdiu

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets